Akne
Senast uppdaterad: Senast reviderad:
Sakkunnig:Tore Särnhult
Definition:
Kronisk inflammatorisk sjukdom i talgkörtlarna/hårfolliklarna i ansikte och på övre delen av bålen.
Förekomst:
Nästan alla tonåringar får akne, varav 15–20 % har medelsvår till svår akne.
Symtom:
Ofta lokaliserat till ansiktet, halsen, övre delen av bröstet, ryggen och axlarna. Stor variation i utbredning och intensitet.
Kliniska fynd:
Komedoner, pustler, inflammatoriska papulopustler, eventuellt smärtsamma noduli, cystor/ärr.
Diagnostik:
Tilläggsundersökningar är oftast inte nödvändiga.
Behandling:
Behandlingen är en kombination av olika lokala (benzoylperoxid, retinoid, azelain) och eventuellt systemiska läkemedel (antibiotika, hormonella preparat, isotretinoin).
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016 May;74(5):945-73.e33. doi: 10.1016/j.jaad.2015.12.037.PMID: 26897386. PubMed
- Dall'oglio F, Puglisi DF, Nasca MR, Micali G. Acne fulminans. G Ital Dermatol Venereol. 2020 Dec;155(6):711-718. Epub 2020 Oct 21. PMID: 33084268 PubMed
- Stangeland KZ, Huldt-Nystrøm T, Li X, Danielsen K. Behandling av akne. Tidsskr Nor Legeforen 2019. doi:10.4045/tidsskr.18.0946 DOI
- Behandling av akne – behandlingsrekommendation. Läkemedelsverket (2014). www.lakemedelsverket.se
- Mahmood NF, Shipman AR. The age-old problem of acne. Int J Womens Dermatol 2017 ; 3(2): 71-76. pmid:28560299 PubMed
- Cunliffe WJ, Holland DB, Clark SM et al. Comedogenesis: some new aethiological, clinical and therapeutic strategies. Br J Dermatol 2000; 142; 1084-91.
- Kluznic AR, Wood EJ, Cunliffe WJ. Keratin characterization in the pilosebaceous ducts of acne pasients. I: Marks R, Plewig G, red. Acne and related disorders. London: Martin Dunitz, 1989: 113-5.
- Mikkelsen CS, Hansen SR, Kroon S. Lokalbehandling av akne. Tidsskr Nor Legeforen 2011. doi:10.4045/tidsskr.09.1312 DOI
- Thiboutot D, Zaenglein A. Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris. UpToDate, last updated Nov 12, 2019. www.uptodate.com
- Bowe WP, Joshi SS, Shalita AR. Diet and acne. J Am Acad Dermatol 2010; 63: 124-41. PubMed
- Zaenglein AL, Pathy AL, Schlosser BJ et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016 May;74(5):945-73.e33. doi: 10.1016/j.jaad.2015.12.037. Epub 2016 Feb 17. Erratum in: J Am Acad Dermatol. 2020 Jun;82(6):1576. PMID: 26897386 PubMed
- Maroñas-Jiménez L, Krakowski AC. Pediatric Acne: Clinical Patterns and Pearls. Dermatol Clin. 2016 Apr;34(2):195-202. PMID: 27015779. PubMed
- Thiboutot D, Zaenglein A, Weiss J, et al. An aqueous gel fixed combination of clindamycin phosphate 1,2% and benzoyl peroxide 2,5% for the once-daily treatment of moderate to severe acne vulgaris: Assessment of efficacy and safety in 2813 patients. J Am Acad Dermatol 2008; : PMID: 18805603. PubMed
- Zouboulis CC, Bettoli V. Management of severe acne. Br J Dermatol 2015. pmid: 25597508 PubMed
- Graber E. Acne vulgaris. Overview of management. UpToDate, last updated Feb 17, 2021. www.uptodate.com
- Burris J, Rietkerk W, Shikany JM, Woolf K. Differences in Dietary Glycemic Load and Hormones in New York City Adults with No and Moderate/Severe Acne. J Acad Nutr Diet. 2017 Sep;117(9):1375-1383. PMID: 28606553 PubMed
- Bhate K, Williams HC. What's new in acne? An analysis of systematic reviews published in 2011-2012. Clin Exp Dermatol. 2014 Apr;39(3):273-7; quiz 277-8. doi: 10.1111/ced.12270.
- Yang Z, Zhang Y, Lazic Mosler E, Hu J, Li H, Zhang Y, Liu J, Zhang Q. Topical benzoyl peroxide for acne. Cochrane Database Syst Rev. 2020 Mar 16;3(3):CD011154. doi: 10.1002/14651858.CD011154.pub2. PMID: 32175593 PubMed
- Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol 2008; 158: 208-16. PubMed
- Ross JI, AM Snelling AM, Carnegi E et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-78. PubMed
- Wolf JE, Kaplan D, Kraus J. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and klindamycin. J Am Acad Dermatol 2003; 49: S211-7. PubMed
- Begränsningar i användningen av cyproteron på grund av risk för meningeom. Nyheter 2020-02-19 lakemedelsverket.se
- Eichenfield DZ, Sprague J, Eichenfield LF. Management of Acne Vulgaris: A Review. JAMA. 2021 Nov 23;326(20):2055-2067. doi: 10.1001/jama.2021.17633. PMID: 34812859 PubMed
- Blasiak RC, Stamey CR, Burkhart CN, et al. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris. JAMA Dermatol 2013; 149: 1392. pmid:24173086 PubMed
- Costa CS, Bagatin E, Martimbianco ALC. Oral isotretinoin for acne. Cochrane Database of Systematic Reviews 2018, Issue 11. Art. No.: CD009435. DOI: 10.1002/14651858.CD009435.pub2 DOI
- Hanson N, Leachman S. Safety issues in isotretinoin therapy. Semin Cutan Med Surg 2001; 20: 166-83. PMID: 11594672. PubMed
- Läkemedelsverket, 2013 www.lakemedelsverket.se
- Gollnick H, Cunliffe W, Berson D et al; Global Alliance to Improve Outcomes in Acne. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (suppl): S1-37.
- Kaymak Y, Taner E, Taner Y. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol 2009; 48: 41-6. PubMed
- Tore Särnhult, överläkare, Hallandskustens hudmottagning
- Anna Nager, med dr och specialist i allmänmedicin, Karolinska institutet